Dispersive coupling between MoSe2 and an integrated zero-dimensional nanocavity

Establishing a coherent interaction between a material resonance and an optical cavity is a necessary first step to study semiconductor quantum optics. Here we report on the signature of a coherent interaction between a two-dimensional excitonic transition in monolayer MoSe2 and a zero-dimensional, ultra-low mode volume, V∼ 2(λ/n)^3, on-chip photonic crystal nanocavity. This coherent interaction manifests as a dispersive shift of the cavity transmission spectrum, when the exciton-cavity detuning is decreased via temperature tuning. The exciton-cavity coupling is estimated to be about 6.5 meV, with a cooperativity of about 4.0 at 80 K, showing our material system is on the verge of strong coupling. The small mode-volume of the resonator is instrumental in reaching the strongly nonlinear regime, while on-chip cavities will help create a scalable quantum photonic platform

Bandgap and Band Offsets Determination of Semiconductor Heterostructures using Three-terminal Ballistic Carrier Spectroscopy

Utilizing three-terminal tunnel emission of ballistic electrons and holes, we have developed a method to self-consistently measure the bandgap of semiconductors and band discontinuities at semiconductor heterojunctions without any prerequisite material parameter. Measurements are performed on lattice-matched GaAs/AlxGa1-xAs and GaAs/(AlxGa1-x)0.51In0.49P single-barrier heterostructures. The bandgaps of AlGaAs and AlGaInP are measured with a resolution of several meV at 4.2 K. For the GaAs/AlGaAs interface, the measured Gamma band offset ratio is 60.4:39.6 (+/-2%). For the GaAs/AlGaInP interface, this ratio varies with the Al mole fraction and is distributed more in the valence band. A non-monotonic Al composition dependence of the conduction band offset at the GaAs/AlGaInP interface is observed in the indirect-gap regime.Comment: 4 pages, 4 figures, submitted to Phys. Rev. Lett

Chiral primary cubic interactions from pp-wave supergravity

We explicitly construct cubic interaction light-cone Hamiltonian for the chiral primary system involving the metric fields and the self-dual four-form fields in the IIB pp-wave supergravity. The background fields representing pp-waves exhibit SO(4)*SO(4)*Z_2 invariance. It turns out that the interaction Hamiltonian is precisely the same as that for the dilaton-axion system, except for the fact that the chiral primary system fields have the opposite parity to that of the dilaton-axion fields under the Z_2 transformation that exchanges two SO(4)'s.Comment: 14 pages, A few comments are adde

Gratings with an aperiodic basis: single-mode emission in multi-wavelength lasers

We propose a new class of gratings having multiple spatial frequencies. Their design relies on the use of small aperiodic grating sequences as unit cells whose repetition forms a superlattice. The superlattice provides well-defined Fourier components, while the choice of the unit cell structure enables the selection, modulation or suppression of certain Fourier components. Using these gratings to provide distributed feedback in mid-infrared quantum cascade lasers, we demonstrate simultaneous lasing on multiple well-defined and isolated longitudinal modes, each one having a sidemode suppression ratio of about 20 dB.United States. Air Force Office of Scientific Research (MURI 67N-1069926)Harvard University (Nanoscale Systems and Engineering Center)United States. Air Force (‘Deterministic Aperiodic Structures for Onchip Nanophotonic and Nanoplasmonic Device Applications’ under award no. FA9550-10-1- 0019)National Science Foundation (U.S.) (NSF CAREER Award ECCS-0846651)Georgia Institute of Technology (Steve W. Chaddick Endowed Chair of OptoElectronics

Pharmacokinetics of quinacrine in the treatment of prion disease

BACKGROUND: Prion diseases are caused by the accumulation of an aberrantly folded isoform of the prion protein, designated PrP(Sc). In a cell-based assay, quinacrine inhibits the conversion of normal host prion protein (PrP(C)) to PrP(Sc )at a half-maximal concentration of 300 nM. While these data suggest that quinacrine may be beneficial in the treatment of prion disease, its penetration into brain tissue has not been extensively studied. If quinacrine penetrates brain tissue in concentrations exceeding that demonstrated for in vitro inhibition of PrP(Sc), it may be useful in the treatment of prion disease. METHODS: Oral quinacrine at doses of 37.5 mg/kg/D and 75 mg/kg/D was administered to mice for 4 consecutive weeks. Plasma and tissue (brain, liver, spleen) samples were taken over 8 weeks: 4 weeks with treatment, and 4 weeks after treatment ended. RESULTS: Quinacrine was demonstrated to penetrate rapidly into brain tissue, achieving concentrations up to 1500 ng/g, which is several-fold greater than that demonstrated to inhibit formation of PrP(Sc )in cell culture. Particularly extensive distribution was observed in spleen (maximum of 100 μg/g) and liver (maximum of 400 μg/g) tissue. CONCLUSIONS: The documented extensive brain tissue penetration is encouraging suggesting quinacrine might be useful in the treatment of prion disease. However, further clarification of the distribution of both intracellular and extracellular unbound quinacrine is needed. The relative importance of free quinacrine in these compartments upon the conversion of normal host prion protein (PrP(C)) to PrP(Sc )will be critical toward its potential benefit

Endoscopic Ultrasound-Guided Fine Needle Aspiration and Endoscopic Retrograde Cholangiopancreatography-Based Tissue Sampling in Suspected Malignant Biliary Strictures: A Meta-Analysis of Same-Session Procedures

Background/Aims: The diagnosis of biliary strictures can be challenging. There are no systematic reviews studying same-session endoscopic retrograde cholangiopancreatography (ERCP)-based tissue sampling and endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for the diagnosis of biliary strictures. Methods: A systematic review was conducted on studies analyzing same-session EUS and ERCP for tissue diagnosis of suspected malignant biliary strictures. The primary outcome was the accuracy of each method individually compared to the two methods combined. The secondary outcome was the accuracy of each method in pancreatic and biliary etiologies. In the meta-analysis, we used Forest plots, summary receiver operating characteristic curves, and estimates of the area under the curve for intention-to-treat analysis. Results: Of the 12,132 articles identified, six were included, resulting in a total of 497 patients analyzed. The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and accuracy of the association between the two methods were: 86%, 98%, 12.50, 0.17, and 96.5%, respectively. For the individual analysis, the sensitivity, specificity and accuracy of EUS-FNA were 76%, 100%, and 94.5%, respectively; for ERCP-based tissue sampling, the sensitivity, specificity, and accuracy were 58%, 98%, and 78.1%, respectively. For pancreatic lesions, EUS-FNA was superior to ERCP-based tissue sampling. However, for biliary lesions, both methods had similar sensitivities. Conclusions: Same-session EUS-FNA and ERCP-based tissue sampling is superior to either method alone in the diagnosis of suspected malignant biliary strictures. Considering these results, combination sampling should be performed when possible

D-instanton derivation of multi-fermion F-terms in supersymmetric QCD

We investigate effects of field theory instantons by considering D-instantons in a suitable D3-brane background. In supersymmetric QCD with SU(N_c) gauge group with N_f=N_c flavors, the moduli space of vacua is deformed by instantons. This effect can be described by the chiral interactions which are called multi-fermion F-terms. We derive these chiral interaction terms as D-instanton effects in the presence of D3-branes. For SU(2), the obtained result agrees with the previous result worked out by Beasley and Witten [hep-th/0409149]. We also explicitly work out those for the case of the symplectic gauge group, and show that they describe the deformation of the moduli space.Comment: 25 page

In Vitro Amplification of Misfolded Prion Protein Using Lysate of Cultured Cells

Protein misfolding cyclic amplification (PMCA) recapitulates the prion protein (PrP) conversion process under cell-free conditions. PMCA was initially established with brain material and then with further simplified constituents such as partially purified and recombinant PrP. However, availability of brain material from some species or brain material from animals with certain mutations or polymorphisms within the PrP gene is often limited. Moreover, preparation of native PrP from mammalian cells and tissues, as well as recombinant PrP from bacterial cells, involves time-consuming purification steps. To establish a convenient and versatile PMCA procedure unrestricted to the availability of substrate sources, we attempted to conduct PMCA with the lysate of cells that express cellular PrP (PrPC). PrPSc was efficiently amplified with lysate of rabbit kidney epithelial RK13 cells stably transfected with the mouse or Syrian hamster PrP gene. Furthermore, PMCA was also successful with lysate of other established cell lines of neuronal or non-neuronal origins. Together with the data showing that the abundance of PrPC in cell lysate was a critical factor to drive efficient PrPSc amplification, our results demonstrate that cell lysate in which PrPC is present abundantly serves as an excellent substrate source for PMCA